Contego Medical is a Raleigh-based medical device company with FDA-cleared systems targeting neurovascular, coronary and peripheral vascular disease. In 2018 the company received FDA approval for the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection and for the Paladin Carotid PTA Balloon System, described as the first filter-based Integrated Embolic Protection device. Contego disclosed a new financing in an SEC filing signed by CEO Ravish Sachar. The company sought to raise $22.565 million but the filing indicates it came up roughly $215,000 short of that target. Contego previously raised more than $5 million in 2015. No operating metrics or revenue figures were disclosed in the article. Contego Medical develops the Integrated Embolic Protection™ filter platform for angioplasty balloon and stent delivery catheters. Its product portfolio includes the Paladin® Carotid Post‑Dilation Balloon with Integrated Embolic Protection, which is CE‑marked in Europe but not for sale in the US. The company completed a $5.6M Series B financing to support growth. It will use the funds to expand leadership, sales and engineering teams and to develop new products. Management includes founder and CEO Ravish Sachar MD, COO Paul Sanders, CTO Udayan Patel, European GM Alan Bacharach, and VP of Quality and Clinical Affairs Elizabeth Saylors.

Total raised

$28M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2020